OM Outset Medical Inc
Price (delayed)
$0.599
Market cap
$32.28M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.46
Enterprise value
$106.8M
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to
Highlights
OM's gross margin has surged by 53% year-on-year and by 9% since the previous quarter
OM's gross profit is up by 33% year-on-year and by 9% since the previous quarter
The equity has plunged by 78% YoY and by 44% from the previous quarter
OM's debt is up by 48% YoY
Key stats
What are the main financial stats of OM
Market
Valuations
Earnings
Shares outstanding
53.9M
Market cap
$32.28M
Enterprise value
$106.8M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.17
Price to sales (P/S)
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.94
Revenue
$113.69M
Gross profit
$38.56M
Operating income
-$113.38M
Net income
-$127.98M
EBIT
-$103.61M
EBITDA
-$96.45M
Free cash flow
-$117.22M
Per share
Balance sheet
Liquidity
EPS
-$2.46
EPS diluted
-$2.46
Free cash flow per share
-$2.26
Book value per share
$0.51
Revenue per share
$2.19
TBVPS
$5.31
Total assets
$275.8M
Total liabilities
$248.98M
Debt
$201.86M
Equity
$26.82M
Working capital
$212.84M
Debt to equity
7.53
Current ratio
5.69
Quick ratio
4.36
Net debt/EBITDA
-0.77
Margins
Efficiency
Dividend
EBITDA margin
-84.8%
Gross margin
33.9%
Net margin
-112.6%
Operating margin
-99.7%
Return on assets
-41.6%
Return on equity
-216.5%
Return on invested capital
-25.7%
Return on capital employed
-45%
Return on sales
-91.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OM stock price
How has the Outset Medical stock price performed over time
Intraday
-4.94%
1 week
-17.69%
1 month
-26.05%
1 year
-79.34%
YTD
-46.04%
QTD
-46.04%
Financial performance
How have Outset Medical's revenue and profit performed over time
Revenue
$113.69M
Gross profit
$38.56M
Operating income
-$113.38M
Net income
-$127.98M
Gross margin
33.9%
Net margin
-112.6%
OM's gross margin has surged by 53% year-on-year and by 9% since the previous quarter
Outset Medical's operating income has increased by 33% YoY and by 12% QoQ
OM's gross profit is up by 33% year-on-year and by 9% since the previous quarter
The net income is up by 26% year-on-year and by 9% since the previous quarter
Growth
What is Outset Medical's growth rate over time
Valuation
What is Outset Medical stock price valuation
P/E
N/A
P/B
1.17
P/S
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.94
OM's EPS is up by 29% year-on-year and by 11% since the previous quarter
The equity has plunged by 78% YoY and by 44% from the previous quarter
OM's price to book (P/B) is 72% lower than its 5-year quarterly average of 4.2 and 35% lower than its last 4 quarters average of 1.8
OM's price to sales (P/S) is 98% lower than its 5-year quarterly average of 11.8 and 70% lower than its last 4 quarters average of 0.9
Outset Medical's revenue has decreased by 13% YoY
Efficiency
How efficient is Outset Medical business performance
Outset Medical's ROE has plunged by 111% YoY and by 28% from the previous quarter
The return on invested capital has increased by 45% year-on-year and by 12% since the previous quarter
OM's return on sales is up by 26% year-on-year and by 12% since the previous quarter
Outset Medical's return on assets has increased by 21% YoY and by 7% QoQ
Dividends
What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OM.
Financial health
How did Outset Medical financials performed over time
The total assets is 11% greater than the total liabilities
The total liabilities has grown by 30% year-on-year
OM's quick ratio is down by 13% since the previous quarter
The debt to equity has surged by 78% since the previous quarter
The equity has plunged by 78% YoY and by 44% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.